l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with carbachol in 5 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (carbachol) | Trials (carbachol) | Recent Studies (post-2010) (carbachol) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 13,918 | 81 | 968 |
| Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | carbachol (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.7849 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.0626 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 3.4134 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 2.535 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 2.9961 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 2.6638 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 4.849 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 4.99 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrick, T; Heymann-Mönnikes, I; Livingston, EH; Sierra, A; Taché, Y; Weiner, H | 1 |
| Maeda-Hagiwara, M; Taché, Y | 1 |
| Garrick, T; Sierra, A; Taché, Y; Veiseh, A; Weiner, H | 1 |
| Garrick, T; Taché, Y; Veiseh, A; Weiner, H | 1 |
| LePard, KJ; Mohammed, JR; Stephens, RL | 1 |
5 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and carbachol
| Article | Year |
|---|---|
Bombesin microinjected into the dorsal vagal complex inhibits TRH-stimulated gastric contractility in rats.
Topics: Animals; Bombesin; Carbachol; Cisterna Magna; Gastrointestinal Motility; Injections; Male; Microinjections; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Stomach; Thyrotropin-Releasing Hormone; Vagus Nerve | 1990 |
Central nervous system action of TRH to stimulate gastric emptying in rats.
Topics: Animals; Atropine; Carbachol; Gastric Emptying; Injections, Intravenous; Injections, Intraventricular; Male; Pyrrolidonecarboxylic Acid; Rats; Thyrotropin-Releasing Hormone | 1987 |
Corticotropin-releasing factor acts centrally to suppress stimulated gastric contractility in the rat.
Topics: Animals; Atropine; Carbachol; Cisterna Magna; Corticotropin-Releasing Hormone; Deoxyglucose; Gastrointestinal Motility; Injections, Intravenous; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Reference Values; Thyrotropin-Releasing Hormone | 1988 |
Corticotropin-releasing factor acts on the brain to reduce gastric contractility.
Topics: Animals; Brain; Carbachol; Corticotropin-Releasing Hormone; Deoxyglucose; Dose-Response Relationship, Drug; Gastric Emptying; Injections, Intraventricular; Pyrrolidonecarboxylic Acid; Rats; Stomach; Thyrotropin-Releasing Hormone | 1987 |
Gastric ECL-cell hyperplasia produces enhanced basal and stimulated gastric acid output but not gastric erosion formation in the rat.
Topics: Animals; Carbachol; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa; Histamine; Hyperplasia; Indomethacin; Pentagastrin; Pyrrolidonecarboxylic Acid; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Thyrotropin-Releasing Hormone | 1997 |